These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26851393)

  • 1. Systemic administration of RANKL overcomes the bottleneck of oral vaccine delivery through microfold cells in ileum.
    Maharjan S; Singh B; Jiang T; Yoon SY; Li HS; Kim G; Gu MJ; Kim SJ; Park OJ; Han SH; Kang SK; Yun CH; Choi YJ; Cho CS
    Biomaterials; 2016 Apr; 84():286-300. PubMed ID: 26851393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered Nanoparticles inside a Microparticle Oral System for Enhanced Mucosal and Systemic Immunity.
    Surwase SS; Shahriar SMS; An JM; Ha J; Mirzaaghasi A; Bagheri B; Park JH; Lee YK; Kim YC
    ACS Appl Mater Interfaces; 2022 Mar; 14(9):11124-11143. PubMed ID: 35227057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Rel is dispensable for the differentiation and functional maturation of M cells in the follicle-associated epithelium.
    Sehgal A; Kobayashi A; Donaldson DS; Mabbott NA
    Immunobiology; 2017 Feb; 222(2):316-326. PubMed ID: 27663963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated membrane IgA+ and CD4+ (T helper) populations in murine Peyer's patch and splenic lymphocytes during dietary administration of the trichothecene vomitoxin (deoxynivalenol).
    Pestka JJ; Dong W; Warner RL; Rasooly L; Bondy GS; Brooks KH
    Food Chem Toxicol; 1990 Jun; 28(6):409-20. PubMed ID: 2145206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble RANKL expression in Lactococcus lactis and investigation of its potential as an oral vaccine adjuvant.
    Kim JI; Park TE; Maharjan S; Li HS; Lee HB; Kim IS; Piao D; Lee JY; Cho CS; Bok JD; Hong ZS; Kang SK; Choi YJ
    BMC Immunol; 2015 Nov; 16():71. PubMed ID: 26608025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RANKL regulates differentiation of microfold cells in mouse nasopharynx-associated lymphoid tissue (NALT).
    Mutoh M; Kimura S; Takahashi-Iwanaga H; Hisamoto M; Iwanaga T; Iida J
    Cell Tissue Res; 2016 Apr; 364(1):175-84. PubMed ID: 26553655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues.
    Xu-Amano J; Kiyono H; Jackson RJ; Staats HF; Fujihashi K; Burrows PD; Elson CO; Pillai S; McGhee JR
    J Exp Med; 1993 Oct; 178(4):1309-20. PubMed ID: 8376936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attuning hydroxypropyl methylcellulose phthalate to oral delivery vehicle for effective and selective delivery of protein vaccine in ileum.
    Singh B; Maharjan S; Jiang T; Kang SK; Choi YJ; Cho CS
    Biomaterials; 2015 Aug; 59():144-59. PubMed ID: 25968463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinatorial Approach of Antigen Delivery Using M Cell-Homing Peptide and Mucoadhesive Vehicle to Enhance the Efficacy of Oral Vaccine.
    Singh B; Maharjan S; Jiang T; Kang SK; Choi YJ; Cho CS
    Mol Pharm; 2015 Nov; 12(11):3816-28. PubMed ID: 26394158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of mucosal dendritic cell function by receptor activator of NF-kappa B (RANK)/RANK ligand interactions: impact on tolerance induction.
    Williamson E; Bilsborough JM; Viney JL
    J Immunol; 2002 Oct; 169(7):3606-12. PubMed ID: 12244151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic and mucosal immunity induced by attenuated Salmonella enterica serovar Typhimurium expressing ORF7 of porcine reproductive and respiratory syndrome virus.
    Han YW; Kim SB; Rahman M; Uyangaa E; Lee BM; Kim JH; Park KI; Hong JT; Han SB; Eo SK
    Comp Immunol Microbiol Infect Dis; 2011 Jul; 34(4):335-45. PubMed ID: 21543119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mucosal vaccine targeting Peyer's patch M cells induces protective antigen-specific IgA responses.
    Shima H; Watanabe T; Fukuda S; Fukuoka S; Ohara O; Ohno H
    Int Immunol; 2014 Nov; 26(11):619-25. PubMed ID: 24908678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RANKL is necessary and sufficient to initiate development of antigen-sampling M cells in the intestinal epithelium.
    Knoop KA; Kumar N; Butler BR; Sakthivel SK; Taylor RT; Nochi T; Akiba H; Yagita H; Kiyono H; Williams IR
    J Immunol; 2009 Nov; 183(9):5738-47. PubMed ID: 19828638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of systemic and mucosal immune responses following immunization with somatostatin-avidin complexes incorporated into ISCOMS.
    Estrada A; Laarveld B; Li B; Redmond MJ
    Immunol Invest; 1995 Aug; 24(5):819-28. PubMed ID: 8543345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new vaccine targeting RANKL, prepared by incorporation of an unnatural Amino acid into RANKL, prevents OVX-induced bone loss in mice.
    Li F; Li H; Zhai Q; Li F; Wu T; Sha X; Zhang B; Yang W; Lu Z; Tao H
    Biochem Biophys Res Commun; 2018 May; 499(3):648-654. PubMed ID: 29604276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRC2 Regulated Atoh8 Is a Regulator of Intestinal Microfold Cell (M Cell) Differentiation.
    George JJ; Martin-Diaz L; Ojanen MJT; Gasa R; Pesu M; Viiri K
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgA responses in xid mice: oral antigen primes Peyer's patch cells for in vitro immune responses and secretory antibody production.
    Kiyono H; Mosteller LM; Eldridge JH; Michalek SM; McGhee JR
    J Immunol; 1983 Dec; 131(6):2616-22. PubMed ID: 6227659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of antigen-specific immune responses in anti-IL-7 receptor alpha chain antibody-treated Peyer's patch-null mice following intestinal immunization with microencapsulated antigen.
    Kunisawa J; Takahashi I; Okudaira A; Hiroi T; Katayama K; Ariyama T; Tsutsumi Y; Nakagawa S; Kiyono H; Mayumi T
    Eur J Immunol; 2002 Aug; 32(8):2347-55. PubMed ID: 12209648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orally administered OVA/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice.
    Alignani D; Maletto B; Liscovsky M; Rópolo A; Morón G; Pistoresi-Palencia MC
    J Leukoc Biol; 2005 Jun; 77(6):898-905. PubMed ID: 15758079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen.
    Stanisz AM; Befus D; Bienenstock J
    J Immunol; 1986 Jan; 136(1):152-6. PubMed ID: 2415614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.